Report cover image

Global Nystatin API Market Growth 2025-2031

Published Feb 20, 2025
Length 77 Pages
SKU # LPI19640824

Description

The global Nystatin API market size is predicted to grow from US$ 35.2 million in 2025 to US$ 43.6 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.

Nystatin API (Active Pharmaceutical Ingredient) is the raw material of a polyene - type antifungal drug. It is extracted from the culture broth of Streptomyces noursei and its main component is nystatin. It is a complex compound that belongs to the macrolide antibiotics family and has a conjugated polyene structure.

United States market for Nystatin API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Nystatin API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Nystatin API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Nystatin API players cover Antibiotice, Centrient Pharmaceuticals, Duchefa Farma, VUAB Pharma, Hubei Hengshuo Chemical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Nystatin API Industry Forecast” looks at past sales and reviews total world Nystatin API sales in 2024, providing a comprehensive analysis by region and market sector of projected Nystatin API sales for 2025 through 2031. With Nystatin API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nystatin API industry.

This Insight Report provides a comprehensive analysis of the global Nystatin API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nystatin API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nystatin API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nystatin API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nystatin API.

This report presents a comprehensive overview, market shares, and growth opportunities of Nystatin API market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Nystatin Non-micronized
Nystatin Micronized
Nystatin Compacted

Segmentation by Application:
External Preparations
Oral Preparations

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Antibiotice
Centrient Pharmaceuticals
Duchefa Farma
VUAB Pharma
Hubei Hengshuo Chemical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nystatin API market?

What factors are driving Nystatin API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nystatin API market opportunities vary by end market size?

How does Nystatin API break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

77 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Nystatin API by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Nystatin API by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.